Jones Christy
SEC Form 4 insider trading activity
Jones Christy has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jun 25, 2026.
On the most recent filing, Jones Christy is listed as Director at Beta Bionics, Inc. Inside the rolling window, Jones Christy reported no open-market purchases and 3 open-market sales totaling $80K in BBNX. The largest disclosed transaction in the window is a sale of 2,811 BBNX shares on Jun 4, 2026, worth $39K.
Companies traded
Other insiders at BBNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$80K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jones Christy made?
Jones Christy has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Jones Christy trade?
Jones Christy has filed SEC Form 4 disclosures for 1 company, including BBNX.
When was Jones Christy's most recent SEC Form 4 filing?
Jones Christy's most recent SEC Form 4 filing on Tracefour is dated Jun 25, 2026.
What is Jones Christy's total buy and sell value in the current window?
Inside the rolling retention window, Jones Christy bought $0 and sold $80K based on SEC Form 4 filings.
What was Jones Christy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,811 BBNX shares on 2026-06-04, worth $39K, per SEC Form 4 filings.